1Division of Gynecology, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN
2Department of Surgery, Mayo Clinic, Rochester, MN
3Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN
4Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN
5Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN
6Department of Neurology, Mayo Clinic, Rochester, MN.
Address correspondence to: Shannon K. Laughlin-Tommaso, MD, MPH, Division of Gynecology, Department of Obstetrics and Gynecology, 200 First Street SW, Rochester, MN 55905. E-mail: [email protected]
Received 31 January, 2019
Revised 5 June, 2019
Accepted 5 June, 2019
Funding/support: This study was supported by the Office of Research on Women's Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development Building Interdisciplinary Research Careers in Women's Health (BIRCWH, K12 HD065987-2), the National Institute on Aging (R01 AG034676 and U54 AG044170), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD060503). WAR was partly supported by the National Institutes of Health (R01 AG034676, R01 AG052425, U54 AG044170, U01 AG006786, and P01 AG004875).
Financial disclosure/conflicts of interest: EAS receives funding from Bayer. SKL-T consults for Allergan, has a research grant from Bayer, is on the DSMB for the ULTRA trial (Halt Medical), and receives royalties from UpToDate for fibroid articles. For the remaining authors, none were declared.
The abstract was presented at the Society for Gynecologic Investigation Annual Meeting, Florence, Italy, March 2014.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).
